Search

everythinglearnresearchcommunity

for

Search:↓

Topical olive oil protects mice skin from harmful electromagnetic radiation.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

A new hydrogel made from human cells improves wound healing by working with immune cells to promote repair.

PRP therapy shows promise in healing and tissue repair across various medical fields but needs more research for standardization and optimization.

Activins and follistatins, part of the TGFβ family, are crucial for hair follicle development and skin health, affecting growth, repair, and the hair cycle.

IL-1β inhibits human hair follicle growth.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

Topical treatments led to hair regrowth in a man with linear morphea.

Stress-related substance P may lead to hair loss and negatively affect hair growth.

Activin helps skin growth and healing mainly through stromal cells and affects keratinocytes based on its amount.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

RPGRIP1L helps skin cells stick together by blocking PKCβII, which can prevent skin blistering like in pemphigus.

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Early hair loss may indicate risk of insulin resistance.

Manipulating the catagen and telogen phases of hair growth could lead to treatments for hair disorders.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Ketoconazole shampoo improves hair growth and reduces oil similarly to minoxidil in male pattern hair loss.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Platelet-rich plasma may help in skin and hair treatments, and with muscle and joint healing, but more research is needed to fully understand its benefits and limitations.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Using fat-derived stem cells for hair loss treatment is safe and effective, improving hair growth and patient satisfaction.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.